 Chinook Therapeutics Inc NASDAQ: KDNY and Evotec SE OTCMKTS: EVTCY have collaborated for the discovery and development of precision medicine therapies for patients with chronic kidney diseases CKD. Based on Evotecs proprietary comprehensive molecular datasets, Chinook and Evotec will jointly identify, characterize and validate novel mechanisms and discover and develop precision medicines. 